These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18411240)

  • 1. Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2).
    Martin D; Bellanné-Chantelot C; Deschamps I; Froguel P; Robert JJ; Velho G
    Diabetes Care; 2008 Jul; 31(7):1321-3. PubMed ID: 18411240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.
    Massa O; Meschi F; Cuesta-Munoz A; Caumo A; Cerutti F; Toni S; Cherubini V; Guazzarotti L; Sulli N; Matschinsky FM; Lorini R; Iafusco D; Barbetti F;
    Diabetologia; 2001 Jul; 44(7):898-905. PubMed ID: 11508276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity.
    Velho G; Hattersley AT; Froguel P
    Diabetologia; 2000 Aug; 43(8):1060-3. PubMed ID: 10990085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Maturity-onset diabetes of the young 2 with a novel mutation of glucokinase gene in a Chinese boy and the clinical follow-up].
    Li X; Liu L; Liang C; Sheng H; Zhao X
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):867-71. PubMed ID: 25582477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
    Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
    Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations.
    Vaxillaire M; Pueyo ME; Clément K; Fiet J; Timsit J; Philippe J; Robert JJ; Tappy L; Froguel P; Velho G
    Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
    Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
    Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
    Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
    Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2.
    Loomba-Albrecht LA; Jame M; Bremer AA
    Diabetes Res Clin Pract; 2010 Mar; 87(3):e23-5. PubMed ID: 20015564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations.
    Guenat E; Seematter G; Philippe J; Temler E; Jequier E; Tappy L
    Diabetes Metab; 2000 Nov; 26(5):377-84. PubMed ID: 11119017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperglycemia caused by mutation of GCK gene in 10 patients analysis of clinical and mutation characteristics].
    Zhang J; Yuan K; Ding SX; Kong YM; Zhu JF; Fang YL; Liang L; Fu JF; Wang CL
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):440-444. PubMed ID: 31216801
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young.
    Velho G; Froguel P; Clement K; Pueyo ME; Rakotoambinina B; Zouali H; Passa P; Cohen D; Robert JJ
    Lancet; 1992 Aug; 340(8817):444-8. PubMed ID: 1354782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPSC-derived β cells model diabetes due to glucokinase deficiency.
    Hua H; Shang L; Martinez H; Freeby M; Gallagher MP; Ludwig T; Deng L; Greenberg E; Leduc C; Chung WK; Goland R; Leibel RL; Egli D
    J Clin Invest; 2013 Jul; 123(7):3146-53. PubMed ID: 23778137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.
    Rissanen J; Saarinen L; Heikkinen S; Kekäläinen P; Mykkänen L; Kuusisto J; Deeb SS; Laakso M
    Diabetes Care; 1998 Jul; 21(7):1194-7. PubMed ID: 9653619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY).
    Cuesta-Muñoz AL; Tuomi T; Cobo-Vuilleumier N; Koskela H; Odili S; Stride A; Buettger C; Otonkoski T; Froguel P; Grimsby J; Garcia-Gimeno M; Matschinsky FM
    Diabetes Care; 2010 Feb; 33(2):290-2. PubMed ID: 19903754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.